Mediaire: Transforming Radiology with AI and €12 Million European Investment
Deal News | Nov 13, 2024 | High-Tech Gruenderfonds Manage
Mediaire, a German company specializing in AI-powered diagnostic solutions for MRI imaging, has successfully secured €12 million in a funding round led by LBO France, with additional investments from IBB Ventures and Wille Finance. The funding will enable Mediaire to expand its AI portfolio, which is already being utilized in over 350 hospitals and clinics across Europe, beyond its current focus on brain, prostate, and knee diagnostics in MRI. This development marks a significant phase in Mediaire's growth, highlighting the company's commitment to reducing medical workload and improving patient outcomes by integrating AI into daily diagnostic processes. Mediaire has established partnerships with renowned entities such as Bayer and Sectra, further solidifying its position as a leader in radiology AI in Europe. Investors like HTGF expressed their continued support for Mediaire, emphasizing the transformative potential of its innovative AI solutions in meeting the increasing global demand for fast and accurate diagnostics.
Sectors
- Healthcare Technology
- Artificial Intelligence
Geography
- Germany – Mediaire is a German company leading in AI-powered diagnostic solutions for radiology, headquartered in Germany.
- Europe – The company's impact and investment activities are spread across multiple countries in Europe, highlighting its broad geographic influence.
Industry
- Healthcare Technology – This industry applies to the article because Mediaire is involved in developing AI-powered diagnostic solutions that enhance medical procedures and outcomes in the radiology sector.
- Artificial Intelligence – Mediaire's use of AI to transform radiology diagnostics positions it within the AI industry, showcasing how AI is being leveraged for practical, innovative healthcare solutions.
Financials
- €12 million – The total investment amount raised by mediaire in the European-led financing round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| mediaire | Target Company | Company | German company developing AI-powered diagnostic solutions for MRI imaging. |
| LBO France | Lead Investor | Company | A private equity firm leading the €12 million funding round for mediaire. |
| IBB Ventures | Investor | Company | A participant in the funding round for mediaire, backing its AI-driven healthcare innovations. |
| Wille Finance | Investor | Company | Swiss family office participating in mediaire's funding round. |
| HTGF | Existing Investor | Company | High-Tech Gruenderfonds, an early-stage investor providing continued support to mediaire. |
| LIFTT | Existing Investor | Company | Another supporting investor in mediaire's funding round. |
| Gateway Ventures | Existing Investor | Company | Supporting investor involved in the financing of mediaire. |
| Bayer/Calantic | Partner | Company | Industry partner, collaborating with mediaire in healthcare advancements. |
| Sectra | Partner | Company | Collaborator with mediaire providing support in its AI-driven healthcare innovations. |
| Dr. Andreas Lemke | CEO and Co-founder | Person | CEO and co-founder of mediaire, leading the company's AI diagnostic technology. |
| Matthes Seeling | Investment Director | Person | LBO France's Investment Director, expressing confidence in mediaire's AI solutions. |
| Dr. Angelika Vlachou | Partner | Person | Partner at HTGF, supporting mediaire's growth in the AI diagnostics sector. |